While we found that possession of one or more SOD2 rs4880-T alleles was associated with poorer CF in all study participants, the antioxidant properties of SOD2 may have more impactful consequences for women with breast cancer throughout treatment with the introduction of adjuvant therapy regimens known to increase oxidative burden systemically. The gene discussed is SOD2; the disease is cystic fibrosis.